Latest from glenmark pharmaceuticals
Glenmark Pharma Q4 net profit falls 26 per cent to ₹173 crore
The company's consolidated revenues during the quarter under review, however, rose to ₹3,019 crore as against ₹2,860 crore recorded in the same period last year, posting year-on-year growth of 6 per cent.
Published on May 28, 2022 05:16 PM IST
Glenmark launches 1st nasal spray for treating adult Covid-19 patients in India
The Mumbai-based pharmaceutical company received manufacturing-marketing approval from India’s drug regulator, Drugs Controller General of India (DCGI) for Nitric Oxide Nasal Spray as part of an accelerated approval process.
Published on Feb 09, 2022 12:04 PM IST
Glenmark Life Sciences shares make muted debut, list at 4% premium
Glenmark Life Sciences shares edged higher on debut on stock markets as they rose to ₹751 per share, a premium over the issue price of ₹720 apiece.
Published on Aug 06, 2021 10:59 AM IST
Glenmark, SaNOtize sign deal for Covid nasal spray in India, Asian countries
Glenmark has said the nasal spray is designed to kill the coronavirus in the upper airways, preventing it from incubating and spreading to the lungs.
Published on Aug 02, 2021 12:01 PM IST
Glenmark Life Sciences IPO fully subscribed on Day 1
Glenmark Life Sciences IPO size was reduced to 1.5 crore equity shares after the company garnered ₹454 crore from anchor investors on Monday.
Published on Jul 27, 2021 12:13 PM IST